MiniMed TM 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage
Authors' conclusion
These findings suggest the MiniMed™ 780G system delivers consistent glycemic outcomes across socioeconomic levels, offering a promising avenue for reducing diabetes-related health disparities.
Study context
- Population
- US users of the MiniMed 780G system, stratified by Area Deprivation Index percentile
- Participants
- 40,975 users
- Exposure
- Glycemic outcomes across Area Deprivation Index (ADI) groups
- Outcome
- Glycemic metrics across ADI groups
Methodological detailsstratified by ADI percentile
- Stratified by ADI percentile
Main finding
As reported in the abstract
Mean time in range (TIR), regardless of ADI grouping
73%
Mean time below range (TBR), regardless of ADI grouping
1.3%
Mean time above range (TAR), regardless of ADI grouping
25%
Observational data: associations, not effects.
Further findings
Recommended optimal settings (ROS: active insulin time 2 h and glucose target 100 mg/dL, both >95% of the time)
- Users with ROS achieving consensus-recommended glycemic targets
- at least 68%
- Users achieving consensus-recommended targets in the overall analyzed population
- ∼50%
Original publication
MiniMed TM 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage. Diabetes Technol Ther. Published 12 April 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →